Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 33 (November 20), 2005: pp. 8396-8405
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.03.0312

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zell, J. A.
Right arrow Articles by Anton-Culver, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zell, J. A.
Right arrow Articles by Anton-Culver, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Epidemiology of Bronchioloalveolar Carcinoma: Improvement in Survival After Release of the 1999 WHO Classification of Lung Tumors

Jason A. Zell, S.-H. Ignatius Ou, Argyrios Ziogas, Hoda Anton-Culver

From the Chao Family Comprehensive Cancer Center, Division of Hematology/Oncology, Genetic Epidemiology Research Institute, and Division of Epidemiology, Department of Medicine, School of Medicine, University of California Irvine, Irvine, CA

Address reprint requests to Jason A. Zell, DO, MPH, Division of Hematology/Oncology, University of California Irvine Medical Center, 101 The City Dr S, Orange, CA 92868; e-mail: jzell{at}uci.edu

PURPOSE: Classification changes for bronchioloalveolar carcinoma (BAC) by the WHO in May 1999 narrowed its definition. This study was undertaken in an attempt to characterize the impact of these changes on the epidemiology of BAC.

PATIENTS AND METHODS: This retrospective study involves data analysis from the population-based Cancer Surveillance Programs of three Southern California counties from 1995 to 2003. BAC cases diagnosed after May 1999 are compared with BAC cases before that time by clinicopathologic variables including survival.

RESULTS: Incident cases (11,969) of non–small-cell lung cancer (NSCLC) were analyzed, including 626 cases of BAC (5.2%). Median overall survival (OS) for BAC patients diagnosed after May 1999 (> 53 months) was significantly improved over median OS for BAC patients before May 1999 (32 months; P = .012). This survival benefit remained after adjustment for sex, smoking status, and stage at presentation (hazard ratio for time of diagnosis before May 1999 compared with a diagnosis after May 1999 = 1.43; P = .015). Median OS for non-BAC NSCLC patients diagnosed before May 1999 (9 months) did not differ from the median OS of such patients afterwards (10 months; P = .09).

CONCLUSION: This epidemiologic study is the first to demonstrate a survival advantage for BAC patients diagnosed after May 1999 compared with BAC patients diagnosed before this time—a finding that persists after adjustment for sex, smoking status, and stage at presentation. We believe that this observed survival benefit likely reflects changes in the revised 1999 WHO classification.

Supported by University of California Irvine Divisions of Hematology/Oncology, and Epidemiology.

Presented in part at the 17th annual conference of the California Association of Regional Cancer Registries, San Francisco, CA, March 21, 2005 and at the 11th World Conference on Lung Cancer, Barcelona, Spain, July 6, 2005.

Authors' disclosures of potential conflicts of interest are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
P. De Leyn, J. Moons, J. Vansteenkiste, E. Verbeken, D. Van Raemdonck, P. Nafteux, H. Decaluwe, and T. Lerut
Survival after resection of synchronous bilateral lung cancer
Eur. J. Cardiothorac. Surg., December 1, 2008; 34(6): 1215 - 1222.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S.-H. I. Ou, J. A. Zell, A. Ziogas, and H. Anton-Culver
Prognostic Significance of the Non-Size-Based AJCC T2 Descriptors: Visceral Pleura Invasion, Hilar Atelectasis, or Obstructive Pneumonitis in Stage IB Non-small Cell Lung Cancer Is Dependent on Tumor Size
Chest, March 1, 2008; 133(3): 662 - 669.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Arenberg
Bronchioloalveolar Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 306S - 313S.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Seike, N. Yanaihara, E. D. Bowman, K. A. Zanetti, A. Budhu, K. Kumamoto, L. E. Mechanic, S. Matsumoto, J. Yokota, T. Shibata, et al.
Use of a Cytokine Gene Expression Signature in Lung Adenocarcinoma and the Surrounding Tissue as a Prognostic Classifier
J Natl Cancer Inst, August 15, 2007; 99(16): 1257 - 1269.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. J. Raz, J. A. Zell, S-H. I. Ou, D. R. Gandara, H. Anton-Culver, and D. M. Jablons
Natural History of Stage I Non-Small Cell Lung Cancer: Implications for Early Detection
Chest, July 1, 2007; 132(1): 193 - 199.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Wislez, M. Antoine, N. Rabbe, V. Gounant, V. Poulot, A. Lavole, J. Fleury-Feith, and J. Cadranel
Neutrophils Promote Aerogenous Spread of Lung Adenocarcinoma with Bronchioloalveolar Carcinoma Features
Clin. Cancer Res., June 15, 2007; 13(12): 3518 - 3527.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. Zell, J. M. Rhee, A. Ziogas, S. M. Lipkin, and H. Anton-Culver
Race, Socioeconomic Status, Treatment, and Survival Time among Pancreatic Cancer Cases in California
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 546 - 552.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
C. M. Park, J. M. Goo, H. J. Lee, C. H. Lee, E. J. Chun, and J.-G. Im
Nodular Ground-Glass Opacity at Thin-Section CT: Histologic Correlation and Evaluation of Change at Follow-up
RadioGraphics, March 1, 2007; 27(2): 391 - 408.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. A. Wakelee, E. T. Chang, S. L. Gomez, T. H. Keegan, D. Feskanich, C. A. Clarke, L. Holmberg, L. C. Yong, L. N. Kolonel, M. K. Gould, et al.
Lung Cancer Incidence in Never Smokers
J. Clin. Oncol., February 10, 2007; 25(5): 472 - 478.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. A. Zell, S.-H. I. Ou, A. Ziogas, and H. Anton-Culver
Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis
Ann. Onc., August 1, 2006; 17(8): 1255 - 1262.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Tsurutani, M. S. Ballas, and P. A. Dennis
Overestimating the Influence of the 1999 WHO Classification of Lung Tumors on Survival in Bronchioloalveloar Carcinoma
J. Clin. Oncol., April 20, 2006; 24(12): 1963 - 1963.
[Full Text] [PDF]


Home page
JCOHome page
J. A. Zell, S.-H. I. Ou, A. Ziogas, and H. Anton-Culver
In Reply:
J. Clin. Oncol., April 20, 2006; 24(12): 1963 - 1964.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online